Are you a Knight ADRC affiliated researcher with a news article you would like us to post?
Contact Us
Progress in Early Detection and Treatment of Alzheimer’s Disease (Links to an external site)
Neurologists discuss the major milestones in identifying biomarkers for detecting early Alzheimer’s disease over the past two decades.
Researchers call for clinical trial globalization in Alzheimer’s (Links to an external site)
Globalization of ADRD clinical trials has become a pressing need as 68% of the people living with ADRD will reside in low-middle-income countries (LMICs) by 2025.
Equity for African Americans in Alzheimer’s disease (Links to an external site)
For 20 years, the Knight Alzheimer Disease Research Center has worked to boost diversity in clinical trials.
Alzheimer’s Disease: Blood Test May Detect Condition 3 Years Before Clinical Diagnosis (Links to an external site)
Scientists say they have developed a test that can potentially detect Alzheimer’s disease a few years before people typically get a clinical diagnosis.
US approves Alzheimer’s drug that modestly slows disease (Links to an external site)
“This drug is not a cure. It doesn’t stop people from getting worse, but it does measurably slow the progression of the disease,” said Dr. Joy Snider, a neurologist at Washington University in St. Louis. “That might mean someone could have an extra six months to a year of being able to drive.”